文献速递流行病学与生物统计基础与转化研究

围手术期干预预防术后肺部并发症:系统综述与荟萃分析

Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2020-03-11

7种干预有低或中等质量证据提示可能降低PPC,但多数干预仍需低偏倚风险的新试验验证。

要点

  • 加速康复路径、预防性黏液溶解剂、术后持续气道正压通气等7种干预有低或中等质量证据提示可能减少PPC。
  • 预防性呼吸物理治疗、硬膜外镇痛、加速康复路径和目标导向血流动力学治疗经试验序贯分析支持PPC相对风险降低25%。
  • 中等质量证据显示激励性肺量计对预防PPC无获益。

核心结论

  • 以低质量证据为主,支持多种围手术期干预可降低术后肺部并发症。
  • 临床医生可重新评估其围手术期护理路径,但许多干预仍需低偏倚风险的新试验以获得确切疗效证据。

研究设计与样本

  • 采用GRADE方法总结证据质量,并进行试验序贯分析。

主要发现

  • 未发现高质量证据支持任何干预降低PPC主要结局。
  • 7种干预有低或中等质量证据且置信区间提示可能降低PPC:加速康复路径(RR 0.35,95%CI 0.21至0.58)、预防性黏液溶解剂(0.40,0.23至0.67)、术后持续气道正压通气(0.49,0.24至0.99)、肺保护性术中通气(0.52,0.30至0.88)、预防性呼吸物理治疗(0.55,0.32至0.93)、硬膜外镇痛(0.77,0.65至0.92)和目标导向血流动力学治疗(0.87,0.77至0.98)。
  • 中等质量证据显示激励性肺量计在预防PPC方面无获益。
  • 试验序贯分析调整后,预防性呼吸物理治疗、硬膜外镇痛、加速康复路径和目标导向血流动力学治疗可确信支持PPC相对风险降低25%。

关键数值与推荐

  • 纳入标准:研究非心脏手术前、中、后短期程序化医疗干预的随机对照试验,且PPC结局采用临床诊断标准。
  • 排除标准:手术技术研究或生理/生化结局研究。
  • 主要结局为PPC发生率;次要结局为呼吸道感染、肺不张、住院时间和死亡率。
  • 未测量或比较干预措施的不良反应。

临床怎么用

  • 临床医生可考虑采用有低或中等质量证据支持的干预(如加速康复路径、预防性呼吸物理治疗、硬膜外镇痛等)以降低PPC。
  • 激励性肺量计不推荐用于预防PPC。
  • 应结合患者具体情况和证据质量重新评估围手术期护理路径。

局限性

  • 多数证据质量低,未发现高质量证据。
  • 22项试验因干预措施不够相似未纳入荟萃分析。
  • 未测量或比较干预措施的不良反应。
  • 许多干预的疗效仍需低偏倚风险的新试验确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify, appraise, and synthesise the best available evidence on the efficacy of perioperative interventions to reduce postoperative pulmonary complications (PPCs) in adult patients undergoing non-cardiac surgery. DESIGN: Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: Medline, Embase, CINHAL, and CENTRAL from January 1990 to December 2017. ELIGIBILITY CRITERIA: Randomised controlled trials investigating short term, protocolised medical interventions conducted before, during, or after non-cardiac surgery were included. Trials with clinical diagnostic criteria for PPC outcomes were included. Studies of surgical technique or physiological or biochemical outcomes were excluded. DATA EXTRACTION AND SYNTHESIS: Reviewers independently identified studies, extracted data, and assessed the quality of evidence. Meta-analyses were conducted to calculate risk ratios with 95% confidence intervals. Quality of evidence was summarised in accordance with GRADE methods. The primary outcome was the incidence of PPCs. Secondary outcomes were respiratory infection, atelectasis, length of hospital stay, and mortality. Trial sequential analysis was used to investigate the reliability and conclusiveness of available evidence. Adverse effects of interventions were not measured or compared. RESULTS: 117 trials enrolled 21 940 participants, investigating 11 categories of intervention. 95 randomised controlled trials enrolling 18 062 participants were included in meta-analysis; 22 trials were excluded from meta-analysis because the interventions were not sufficiently similar to be pooled. No high quality evidence was found for interventions to reduce the primary outcome (incidence of PPCs). Seven interventions had low or moderate quality evidence with confidence intervals indicating a probable reduction in PPCs: enhanced recovery pathways (risk ratio 0.35, 95% confidence interval 0.21 to 0.58), prophylactic mucolytics (0.40, 0.23 to 0.67), postoperative continuous positive airway pressure ventilation (0.49, 0.24 to 0.99), lung protective intraoperative ventilation (0.52, 0.30 to 0.88), prophylactic respiratory physiotherapy (0.55, 0.32 to 0.93), epidural analgesia (0.77, 0.65 to 0.92), and goal directed haemodynamic therapy (0.87, 0.77 to 0.98). Moderate quality evidence showed no benefit for incentive spirometry in preventing PPCs. Trial sequential analysis adjustment confidently supported a relative risk reduction of 25% in PPCs for prophylactic respiratory physiotherapy, epidural analgesia, enhanced recovery pathways, and goal directed haemodynamic therapies. Insufficient data were available to support or refute equivalent relative risk reductions for other interventions. CONCLUSIONS: Predominantly low quality evidence favours multiple perioperative PPC reduction strategies. Clinicians may choose to reassess their perioperative care pathways, but the results indicate that new trials with a low risk of bias are needed to obtain conclusive evidence of efficacy for many of these interventions. STUDY REGISTRATION: Prospero CRD42016035662.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Odor PM, Bampoe S, Gilhooly D, et al. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ. 2020. PMID: 32161042. doi:10.1136/bmj.m540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。